stockrowDr. Reddy's Laboratories Ltd
RDY Healthcare Drug Manufacturers Specialty & Generic
Dr. Reddy's Laboratories Ltd’s revenue for fiscal 2026 (year ended March 2026) was $3.6 billion, down 6.06% from fiscal 2025.
- Revenue
- −10.1%
- EPS
- −36.8%
- Free cash flow
- −70.5%
- Total debt
- +14.1%
Quarter to September 2026, against a year earlier
Follow RDY
Alert me
Dr. Reddy's Laboratories Ltd (RDY) Gross margin
Dr. Reddy's Laboratories Ltd's gross margin over the twelve months to 30 September 2026 was 49.2%, down 3.6 percentage points from fiscal 2026 (52.8%). Over the past ten years it has ranged from 52.8% (fiscal 2026) to 59.7% (fiscal 2016) — the current reading is the lowest in ten years. That is below the Drug Manufacturers Specialty & Generic industry median of 53.5% and below the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2026 | 52.8% | (5.74) |
| FY2025 | 58.5% | (0.09) |
| FY2024 | 58.6% | 1.92 |
| FY2023 | 56.7% | 3.57 |
| FY2022 | 53.1% | (1.21) |
| FY2021 | 54.3% | 0.48 |
| FY2020 | 53.8% | (0.41) |
| FY2019 | 54.3% | 0.51 |
| FY2018 | 53.7% | (1.90) |
| FY2017 | 55.6% | (4.02) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 52.1% | 5.59 |
| Jun 2026 | 46.5% | 5.54 |
| Mar 2026 | 41.0% | (12.63) |
| Dec 2025 | 53.6% | (1.04) |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| NBIX Neurocrine Biosciences, Inc. compare | 97.8% |
| KNSA Kiniksa Pharmaceuticals International, plc compare | 90.2% |
| ALKS Alkermes plc compare | 82.9% |
| HIMS Hims & Hers Health, Inc. compare | 68.4% |
| LNTH Lantheus Holdings, Inc. compare | 61.3% |
| ELAN Elanco Animal Health Incorporated compare | 55.4% |
| RDY Dr. Reddy's Laboratories Ltd | 49.2% |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | 40.2% |
| VTRS Viatris Inc. compare | 35.3% |
| Drug Manufacturers Specialty & Generic industry median | 53.5% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on RDY
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement